Science Explorer Back to mapMap
Discussion
Researcher · Asan Medical Center · South Korea

Yoon‐Koo Kang

Yoon‐Koo Kang publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Colorectal Cancer Treatments and Studies.

ORCID 0000-0003-0783-6583 OpenAlex
World rank
#85,587
of 7,710,434 ranked researchers
Rank in South Korea
#384
of 162,609
Works
859
Citations
62k
Citations per work
72.5
h-index
96
i10-index 381Top 0.2% in Pulmonary and Respiratory Medicine
Yoon‐Koo Kang

What does Yoon‐Koo Kang research?

Yoon‐Koo Kang's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 608 works · 70.8% of their workMedicine: 608 works · 70.8% of their workPulmonary and Respiratory Medicine: 191 works · 22.2% of their workOncology: 180 works · 20.9% of their workSurgery: 105 works · 12.2% of their workGastroenterology: 88 works · 10.3% of their workHepatology: 45 works · 5.2% of their workEverything else: 213 works · 24.8% of their workLife Sciences: 38 works · 4.4% of their workBiochemistry, Genetics and Molecular Biology: 38 works · 4.4% of their workMolecular Biology: 38 works · 4.4% of their workTHEIR WORKYoon‐Koo Kang859works
Life Sciences4%Health Sciences71%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine60870.8%
  2. Everything else21324.8%
    1. Biochemistry, Genetics and Molecular Biology384.4%
  1. 1Pulmonary and Respiratory Medicine22% of their works
  2. 2Oncology21% of their works
  3. 3Surgery12% of their works
  4. 4Gastroenterology10% of their works
  5. 5Hepatology5% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Yoon‐Koo Kang's research?

The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Endoscopic Resection, Gastric Cancer, Prognostic Factors, Surgical Management, Imatinib Mesylate and Sunitinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Chemotherapy5273 topics
  2. Clinical Practice Guidelines4122 topics
  3. Endoscopic Resection3191 topic
  4. Gastric Cancer3191 topic
  5. Prognostic Factors2532 topics
  6. Surgical Management2532 topics
  7. Imatinib Mesylate1931 topic
  8. Sunitinib1931 topic
  9. Diagnosis1592 topics
  10. Treatment1592 topics
  11. Cetuximab1471 topic
  12. KRAS Mutations1471 topic
  13. Epidemiology1262 topics
  14. Hepatocellular Carcinoma931 topic
  15. Liver Cancer931 topic
  16. Immune Checkpoint Blockade821 topic
  17. PD-1 and PD-L1821 topic
  18. Intussusception661 topic
  19. Meckel's Diverticulum661 topic
  20. Breast Cancer611 topic
  21. HER2611 topic
  22. Biliary Tract Cancer601 topic
  23. Cholangiocarcinoma601 topic

Where does Yoon‐Koo Kang work?

Yoon‐Koo Kang's main affiliation in the publication record is Asan Medical Center, South Korea.

How many publications and citations does Yoon‐Koo Kang have?

OpenAlex counts 859 works and 62,290 citations for Yoon‐Koo Kang, an h-index of 96, ranking #85,587 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yoon‐Koo Kang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.